Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinchai Xiaoer Feiyan Granules is a Traditional Chinese Medicine (TCM) formulation developed by Xinjiang Tefeng Pharmaceutical for the treatment of pediatric respiratory conditions. It is primarily indicated for acute bronchitis and pneumonia in children, specifically those presenting with wind-heat symptoms according to TCM diagnostic criteria. The formulation is a combination of several herbal extracts, including *Lonicera japonica* (honeysuckle), *Bupleurum*, *Scutellaria baicalensis*, and *Forsythia suspensa*. These ingredients are traditionally utilized for their heat-clearing, detoxifying, and phlegm-resolving properties. Pharmacologically, the granules exhibit anti-inflammatory, antipyretic, and antitussive activities, which help to reduce fever, alleviate cough, and clear airway congestion in pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jinchai xiaoer feiyan granules.